Data / Form D filings / Primus Therapeutics Inc.
Primus Therapeutics Inc.: Form D filings
Primus Therapeutics Inc., a pharmaceuticals company in Skillman, NJ, filed 2 Form D notices with the SEC in 2011. The latest, on February 16, 2011, reports $300,000 sold of a $1 million offering to 2 investors.
Find out what Primus Therapeutics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 23 ORCHARD ROAD, Suite 105, Skillman, NJ, 08558
- Phone
- (800) 903-4131
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1501467
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 16, 2011 | New notice | $1,000,000 | $300,000 | $700,000 | 2 | Jan 25, 2011 | sec.gov |
| Feb 16, 2011 | New notice | $500,000 | $500,000 | $0 | 4 | Jul 12, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Massad | Executive Officer | |
| Andrew Sadosky | Director | |
| Joseph Falsetti | Director | |
| Dennis O'Donnell | Executive Officer, Director | |
| Robert Hariri | Director | |
| Kenneth Taylor | Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Feb 14, 2011 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Primus Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.